United States · FDA National Drug Code directory
Vyepti
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67386-130_ae1b6705-69c6-4f31-8017-2a3abc032d53
- Product NDC
- 67386-130
- Form
- INJECTION
- Composition / generic term
- eptinezumab-jjmr
- Labeler
- Lundbeck Pharmaceuticals LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200221
- Source listing expiry
- 20271231
Source-listed ingredients
- EPTINEZUMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-51) / 1 mL in 1 VIAL, SINGLE-DOSE · 67386-130-51
- 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91) / 1 mL in 1 VIAL, SINGLE-DOSE · 67386-130-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →